Business Description
BioArctic AB
ISIN : SE0010323311
Share Class Description:
BRCTF: Class BCompare
Compare
Traded in other countries / regions
BIOA B.Sweden0RV2.UKBRCTF.USAB9A.Germany IPO Date
2022-11-16Description
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 113.67 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 84.61 | |||||
Beneish M-Score | -3.09 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 114.3 | |||||
3-Year Book Growth Rate | 4.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 20.36 | |||||
9-Day RSI | 37.79 | |||||
14-Day RSI | 46.63 | |||||
6-1 Month Momentum % | -16.05 | |||||
12-1 Month Momentum % | -27.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.49 | |||||
Quick Ratio | 8.49 | |||||
Cash Ratio | 3.81 | |||||
Days Sales Outstanding | 0.32 | |||||
Days Payable | 151.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.03 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.53 | |||||
Operating Margin % | -46.28 | |||||
Net Margin % | -48.44 | |||||
FCF Margin % | -40.27 | |||||
ROE % | -11.64 | |||||
ROA % | -10.52 | |||||
ROIC % | -55.61 | |||||
ROC (Joel Greenblatt) % | -45.51 | |||||
ROCE % | -8.95 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 222.22 | |||||
Price-to-Owner-Earnings | 82.94 | |||||
PS Ratio | 79.56 | |||||
PB Ratio | 20.16 | |||||
Price-to-Tangible-Book | 20.19 | |||||
EV-to-EBIT | -206.62 | |||||
EV-to-Forward-EBIT | 246.24 | |||||
EV-to-EBITDA | -242.55 | |||||
EV-to-Forward-EBITDA | 197.64 | |||||
EV-to-Revenue | 77.43 | |||||
EV-to-Forward-Revenue | 34.12 | |||||
EV-to-FCF | -188.26 | |||||
Price-to-Projected-FCF | 22.58 | |||||
Price-to-Net-Current-Asset-Value | 21 | |||||
Price-to-Net-Cash | 58.33 | |||||
Earnings Yield (Greenblatt) % | -0.48 | |||||
FCF Yield % | -0.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BRCTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioArctic AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 23.013 | ||
EPS (TTM) ($) | -0.14 | ||
Beta | 0 | ||
Volatility % | 45.57 | ||
14-Day RSI | 46.63 | ||
14-Day ATR ($) | 0.287207 | ||
20-Day SMA ($) | 21.958765 | ||
12-1 Month Momentum % | -27.74 | ||
52-Week Range ($) | 15.29 - 30.03 | ||
Shares Outstanding (Mil) | 88.32 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BioArctic AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BioArctic AB Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
BioArctic AB Frequently Asked Questions
What is BioArctic AB(BRCTF)'s stock price today?
The current price of BRCTF is $21.00. The 52 week high of BRCTF is $30.03 and 52 week low is $15.29.
When is next earnings date of BioArctic AB(BRCTF)?
The next earnings date of BioArctic AB(BRCTF) is 2024-08-29.
Does BioArctic AB(BRCTF) pay dividends? If so, how much?
BioArctic AB(BRCTF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |